SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0000950170-23-015782
Filing Date
2023-04-28
Accepted
2023-04-28 16:08:04
Documents
18
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A stsa-20221231.htm   iXBRL 10-K/A 1550794
2 EX-31.1 stsa-ex31_1.htm EX-31 20983
3 EX-31.2 stsa-ex31_2.htm EX-31 20829
4 EX-32.1 stsa-ex32_1.htm EX-32 12102
5 EX-32.2 stsa-ex32_2.htm EX-32 12100
  Complete submission text file 0000950170-23-015782.txt   3385904

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT stsa-20221231_pre.xml EX-101.PRE 347162
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT stsa-20221231_def.xml EX-101.DEF 211923
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT stsa-20221231_cal.xml EX-101.CAL 44394
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT stsa-20221231.xsd EX-101.SCH 56398
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT stsa-20221231_lab.xml EX-101.LAB 462205
12 EXTRACTED XBRL INSTANCE DOCUMENT stsa-20221231_htm.xml XML 10609
Mailing Address 4819 EMPEROR BOULEVARD SUITE 340 DURHAM NC 27703
Business Address 4819 EMPEROR BOULEVARD SUITE 340 DURHAM NC 27703 415-505-0809
Satsuma Pharmaceuticals, Inc. (Filer) CIK: 0001692830 (see all company filings)

IRS No.: 813039831 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-39041 | Film No.: 23866055
SIC: 2834 Pharmaceutical Preparations